期刊文献+

pGEX-4T-3-MFGF21表达载体的构建、表达与纯化 被引量:2

Construction,Expression and Purification of pGEX-4T-3-MFGF21
原文传递
导出
摘要 目的:构建小鼠FGF21(fibroblast growth factor 21,FGF21)重组表达载体pGEX-4T-3-MFGF21,并在大肠杆菌BL21(DE3)中表达,纯化后获得小鼠FGF21融合蛋白。方法:提取小鼠肝脏总RNA后,经RT-PCR扩增获得目的片段,将其克隆至pMD19-T进行保存。以T载体为模板,扩增MFGF21 mat-peptide,构建重组原核表达载体pGEX-4T-3-MFGF21。将重组质粒转化至大肠杆菌菌株BL21(DE3)中,在不同IPTG浓度、温度及转速下对表达载体进行诱导表达,优化表达条件,表达产物经SDS-PAGE电泳以鉴定是否为可溶性表达,采用亲和层析法纯化各表达产物后,进行Western blotting鉴定。结果:成功构建重组表达载体pGEX-4T-3-MFGF21,对其进行可溶性表达后成功纯化出GST-MFGF21,经Western-blotting鉴定为目的蛋白。结论:成功构建pGEX-4T-3-MFGF21,得到纯化的GST-MFGF21蛋白。 Objective:To construct the recombinant expression vector of mouse FGF21 (fibroblast growth factor 21, FGF21 ), express it in the E. coli BL21 (DE3), and obtain the fushion protein of mouse FGF21 after purification. Method: The total RNA was extracted from mouse liver,and the target gene fragment was obtained after RT -PCR. The amplified target gene fragment was cloned into pMD19 -T for preservation. The mat -peptide of MFGF21 gene fragment was ligased with the expression vector of pGEX -4T -3. The pGEX -4T -3 - MFGF21 recombinant was transformed into BI21 ( DE3 ) for expression. The recombination strain was induced in different concentrations of IPTG, kinds of termperature and in various rotate speed. The fusion protein was induced in a best condition, and the product was a soluble one analyzed by SDS - PAGE. The fusion protein was identified by Western blot after being purified with glutathione - agarose. Result: The amplified fragment of mouse FGF21 gene was cloned into pMD19 -T for preservation. The recombinant plasmid of pGEX -4T -3 - MF- GF21 was successfully constructed and expressed in a soluble form, and the GST - MFGF21 protein was also purified. Western blot analy- sis showed that the fusion protein had specific reaction with FGF21 antibody. Conclusion:The pGEX -4T- 3 -MFGF21 recombinant was successfully constructed, and the GST- HFGF21 protein was also purified and obtained.
出处 《生物技术》 CAS CSCD 北大核心 2014年第2期18-24,共7页 Biotechnology
基金 贵州省科技计划项目("FGF21在原发性高血压中的作用机制研究" 编号:LG2011012) 贵阳医学院研究生教育创新计划("FGF21与原发性高血压相关性的研究" 编号:S201109)资助
关键词 小鼠成纤维细胞生长因子(FGF21) pGEX-4T-3 原核表达 蛋白纯化 Mouse FGF21 Cloning Prokaryotic expression Protein purification
  • 相关文献

参考文献12

  • 1Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF - 21, preferentially expressed in the liver [ J ]. Bioehim Biophys Aeta ,2000,1492 ( 1 ) :203 - 206. 被引量:1
  • 2Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho [J]. Biol Chem, 2006, 281 (10):6120 -6123. 被引量:1
  • 3Kharitonenkov A,Dunbar JD,Bina HA,et al. FGF -21/FGF -21 re- ceptor interaction and activation is determined by 13 Klotho [ J]. Cell Physi- ol,2008,215( 1 ) : 1 -7. 被引量:1
  • 4Zhuofeng L,Zhen W,Xiaojing Y,et al. Serum Levels of FGF -21 are increased in coronary heart disease patients and are independently asoociat- ed with adverse lipid profile [J]. Plosone,2010,5(12) :1 -6. 被引量:1
  • 5Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses he- patic steatosis,increases energy expenditure.and improves insulin sensitivity in diet - induced obes mice [ J ]. Diabetes,2009,58 ( 1 ) :250 - 259. 被引量:1
  • 6Mashili FL, Austin RL, Deshmukh AS,et al. Direct effects of FGF21 on glucose uptake in human skeletal muscle:implications for type 2 diabetes and obesity [ J ]. Diabetes Metab Res Rev,2011,27 (3) :286 -297. 被引量:1
  • 7Wang H, Xiao Y, Fu L, et al. High - level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia eoli [ J ]. BMC Biotechnololy,2010, ( 10 ) : 14. 被引量:1
  • 8Inagaki T, Lin VY, Goetz R, et al. Inhibition of growth hormone signa- ling by the fasting- induced hormone FGF21 [J]. Call Metab,2008,8 ( 1 ) :77 - 83. 被引量:1
  • 9Kliewer SA, Mangelsdorf DJ. Fibroblast growth factor 21 :from pharma- cology to physiology [ J ]. Am J Clin Nutr,2010,91 ( I ) : 254S - 257 S. 被引量:1
  • 10张谢,王周光,李晓霞,时洪雪,朱小静,李校堃,肖健.一个新的代谢调节因子——成纤维细胞生长因子21[J].药物生物技术,2011,18(3):269-272. 被引量:2

二级参考文献26

  • 1Kharitonenkov A. FGFs and metabolism [J]. Curr Opin Pharmacol, 2009,9 : 805. 被引量:1
  • 2Kharitonenkov A, Shanafelt AB. Fibroblast growth factor- 21 as a therapeutic agent for metabolic diseases [J]. Bio- Drugs, 2008,22 : 37. 被引量:1
  • 3Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF- 21 as a novel metabolic regulator [J]. J Clin Invest, 2005,115 : 1627. 被引量:1
  • 4Coskun T, HollyA. B, MichaelA. S, et al. Fibroblast growth factor 21 corrects obesity in mice [J]. Ercorcrine So- ciety, 2008,149(2) : 6018. 被引量:1
  • 5Shinohara K, Shoji T, Emoto M, et al. Insulin resistance as an independent predictor of cardiovascular mortality in pa- tients with endstage renal disease [J]. J Am Soc Nephrol, 2002,13 = 1894. 被引量:1
  • 6Zhang X, Ibrahimi OA, Olsen SK, etal. Receptor specificity of the fibroblast growth factor family [J]. J Biol Chem, 2006,281 (23) : 15694. 被引量:1
  • 7Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF - 21, preferentially expressed in the liver [J]. Biochim Biophys Acta, 2000,1492 : 203. 被引量:1
  • 8Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha mediated induction of fibroblast growth factor 21 [J]. Cell Meta, 2007,5 : 415. 被引量:1
  • 9Stevenson EJ, Koncarevic A, Giresi PG, et al. Transcrip- tional profile of a myotube starvation model of atrophy[J]. J Appl Physiol, 2005,98: 1396. 被引量:1
  • 10Badman MK, Pissios P, Kennedy AR, et al. Hepatic fibro- blast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotie states [J]. Cell Meta, 2007,5:426. 被引量:1

共引文献1

同被引文献39

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部